14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:HZNP
Delisted

Horizon Therapeutics Public Ltd Co Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Drug Manufacturers—General
Open Broker Account
$116.30
+0 (+0%)
At Close: Jan 04, 2024
Forecast Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $116.30 $116.30 Thursday, 4th Jan 2024 HZNP stock ended at $116.30. During the day the stock fluctuated 0% from a day low at $116.30 to a day high of $116.30.
90 days $116.30 $116.30
52 weeks $90.61 $116.38

Historical Horizon Therapeutics Public Limited Company prices

Date Open High Low Close Volume
Nov 28, 2023 $116.30 $116.30 $116.30 $116.30 0
Nov 27, 2023 $116.30 $116.30 $116.30 $116.30 0
Nov 24, 2023 $116.30 $116.30 $116.30 $116.30 0
Nov 22, 2023 $116.30 $116.30 $116.30 $116.30 0
Nov 21, 2023 $116.30 $116.30 $116.30 $116.30 0
Nov 20, 2023 $116.30 $116.30 $116.30 $116.30 0
Nov 17, 2023 $116.30 $116.30 $116.30 $116.30 0
Nov 16, 2023 $116.30 $116.30 $116.30 $116.30 0
Nov 15, 2023 $116.30 $116.30 $116.30 $116.30 0
Nov 14, 2023 $116.30 $116.30 $116.30 $116.30 0
Nov 13, 2023 $116.30 $116.30 $116.30 $116.30 0
Nov 10, 2023 $116.30 $116.30 $116.30 $116.30 0
Nov 09, 2023 $116.30 $116.30 $116.30 $116.30 0
Nov 08, 2023 $116.30 $116.30 $116.30 $116.30 0
Nov 07, 2023 $116.30 $116.30 $116.30 $116.30 0
Nov 06, 2023 $116.30 $116.30 $116.30 $116.30 0
Nov 03, 2023 $116.30 $116.30 $116.30 $116.30 0
Nov 02, 2023 $116.30 $116.30 $116.30 $116.30 0
Nov 01, 2023 $116.30 $116.30 $116.30 $116.30 0
Oct 31, 2023 $116.30 $116.30 $116.30 $116.30 0
Oct 30, 2023 $116.30 $116.30 $116.30 $116.30 0
Oct 27, 2023 $116.30 $116.30 $116.30 $116.30 0
Oct 26, 2023 $116.30 $116.30 $116.30 $116.30 0
Oct 25, 2023 $116.30 $116.30 $116.30 $116.30 0
Oct 24, 2023 $116.30 $116.30 $116.30 $116.30 0
Click to get the best stock tips daily for free!

About Horizon Therapeutics Public Limited Company

Horizon Therapeutics Public Limited Company Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-... HZNP Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT